Regulatory Affairs and Intellectual Property Rights

Intellectual property (IP)  is a category of property that includes intangible creations of the human intellect.Intellectual property encompasses two types of rights: industrial property rights (trademarks, patents, designations of origin, industrial designs and models) and copyright.It was not until the 19th century that the term "intellectual property" began to be used, and not until the late 20th century that it became commonplace in the majority of the world

Regulatory affairs (RA), also called government affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, agrochemicals (plant protection products and fertilizers), energy, banking, telecom etc. Regulatory affairs also has a very specific meaning within the healthcare industries (pharmaceuticals, medical devices, biologics and functional foods).

Regulatory affairs (medical affairs) professionals (aka regulatory professionals) usually have responsibility for the following general areas;

Working with federal, state, and local regulatory agencies and personnel on specific issues affecting their business, i.e., working with such agencies as the Food and Drug Administration or European Medicines Agency (pharmaceuticals and medical devices); The Department of Energy; or the Securities and Exchange Commission (banking).

Advising their companies on the regulatory aspects and climate that would affect proposed activities. i.e. describing the "regulatory climate" around issues such as the promotion of prescription drugs and Sarbanes-Oxley compliance.

The Agreement provides norms and standards in respect of following areas of intellectual properties are Patents, Trademarks, copyrights, Geographical indications, Industrial designs.

 

 

    Related Conference of Regulatory Affairs and Intellectual Property Rights

    January 22-23, 2021

    1 st Global Summit on Generic Drugs and Quality Control

    Prague, Czech Republic
    January 22-23, 2021

    1 st World Congress on Rare Diseases & Orphan Drugs

    Prague, Czech Republic
    February 26-27, 2021

    2nd Annual Congress on Antibiotics and Bacterial Infections

    Geneva, Switzerland
    March 10-11, 2021

    6th Pharmaceutical Chemistry Conference

    Paris, France
    March 16-17, 2021

    14th Global Pharmacovigilance And Clinical Trials Summit

    Albufeira, Portugal
    April 11-12, 2021

    2 nd World Pharma Expo

    Tokyo, Japan
    April 12-13, 2021

    2nd International Conference on Biosimilars & Pharmaceuticals

    Auckland, Newzealand
    April 28-29, 2021

    31st Annual European Pharma Congress

    London, UK
    April 28-29, 2021

    14th European Biosimilars Congress

    London, UK
    May 10-11, 2021

    20th Annual Meet on Pharmaceutical Sciences

    Yokohama, Japan
    May 12-12, 2021

    27th Cognitive Neuroscience Congress

    London, UK
    May 17-18, 2021

    8th European Biopharma Congress

    Prague, Czech Republic
    May 19-20, 2021

    36th World Pharmacology and Therapeutics Forum

    Singapore, Singapore
    June 07-08, 2021

    2rd European Conference on Pharmacovigilance and Drug Safety

    Prague, Czech Republic
    July 10-11, 2021

    2 nd Pharma Expo China

    Tokyo, Japan
    August 16-17, 2021

    Global summit on Cosmetic & Reconstructive Surgery

    Tokyo, Japan
    August 16-17, 2021

    34rd World Congress on Pharmacology

    London, UK
    October 05-06, 2021

    International Congress on Drug Delivery

    Auckland, Newzealand
    October 29-30, 2021

    14th World Drug Delivery Summit

    Vancouver, Canada
    October 29-30, 2021

    12th Annual Biomarkers and Clinical Research Congress

    Vancouver, Canada
    November 16-17, 2021

    World Congress on Biologics and Biosimilars

    Osaka, Japan
    December 02-03, 2021

    2nd International conference on Pharma Industry & pharmaceuticals

    Auckland, Newzealand
    December 02-03, 2021

    International Conference on Bio Pharmaceutics

    Auckland, Newzealand
    December 07-08, 2021

    2nd International Conference on Biotechnology and Healthcare

    Auckland, Newzealand
    December 15-16, 2021

    12th World Congress on Bioavailability and Bioequivalence

    Bali, Indonesia
    December 15-16, 2021

    12th World Congress on Bioavailability and Bioequivalence

    Prague, Czech Republic

    Regulatory Affairs and Intellectual Property Rights Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in